About Hans Bishop
Hans Bishop is the Chairman of Sana Biotechnology and the Chief Executive Officer of GRAIL. He has more than 30 years of experience in the biotechnology industry. Hans founded Juno Therapeutics in 2013 and served as its President and Chief Executive Officer until the company's acquisition by Celgene.